Gustav Hanghøj Gram
Chief Executive Officer (CEO)
Gustav Hanghøj Gram (Danish, Born 1993) joined Pila Pharma in 2016 and has held various positions in Pila Pharma within business administration and finance until he in April 2024 was appointed CEO of Pila Pharma AB, Sweden.
In his role as CEO, he will continue a 7-year strong collaboration with the new working Chairman of the Board, founder and previous CEO, Dorte X. Gram. Going forward, Gustav will focus mainly on finance and investor relations including share performance.
Gustav Hanghøj Gram graduated from University of Copenhagen in 2017 including exchange studies at Federal University of Minas Gerais, Brazil, majoring in business administration, communication, international relations, languages & diplomacy.
Gustav started his professional career with an internship at the Danish Consulate in São Paulo, Brazil where he worked together with the commerce department to facilitate export opportunities for Danish companies. Further work included market and sector analysis, trade fair preparations in anticipation of the Danish delegation to the 2016 Rio de Janeiro Olympics and assistance of consular services.
Gustav is CEO and co-owner of Gram Equity Invest AB, Sweden (Family Office), and he speaks fluent Danish, English and Portuguese and proficiently Spanish and Swedish.
Gustav has a keen and increasing interest in human health, global sustainable development, public health matters and what constitutes good healthy lifestyle together with modern day pharmacological product use. He shares the same vision of founder Dorte X. Gram of doing well financially by bringing good products forward to those most in need where economies of scale has the impact. Gustav believes Pila Pharma’s solutions should always aspire to be truly global.
Share ownership in the company: 28232 (direct & indirect)
